Published in N Engl J Med on February 19, 2015
Natural Berry Extract Treatment of Hemangiomas (Pediaberry) | NCT04020419
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study. EBioMedicine (2016) 1.16
Oral Propranolol for Infantile Hemangioma. N Engl J Med (2015) 1.12
The changing face of complicated infantile hemangioma treatment. Pediatr Radiol (2016) 1.00
Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci Transl Med (2016) 0.86
The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol. Adv Ther (2016) 0.81
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. Orphanet J Rare Dis (2015) 0.81
Clinical Characteristics and Treatment Options of Infantile Vascular Anomalies. Medicine (Baltimore) (2015) 0.81
Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study. Sci Rep (2016) 0.79
Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation. Stem Cells Transl Med (2015) 0.79
Oral Propranolol for Infantile Hemangioma. N Engl J Med (2015) 0.79
Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr (2015) 0.79
Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis. PLoS One (2015) 0.79
Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway. Oncotarget (2016) 0.78
Oral atenolol therapy for proliferating infantile hemangioma: A prospective study. Medicine (Baltimore) (2016) 0.78
Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol. JAAD Case Rep (2016) 0.78
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience (2016) 0.76
Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression. J Virol (2015) 0.76
Infantile Hepatic Hemangioendothelioma: An Uncommon Cause of Persistent Pulmonary Hypertension in a Newborn Infant. AJP Rep (2016) 0.75
Propanolol effectively treats significant infantile hemangiomas. J Pediatr (2015) 0.75
Psoriasiform Diaper Rash Possibly Induced by Oral Propranolol in an 18-Month-Old Girl with Infantile Hemangioma. Case Rep Dermatol (2016) 0.75
Repurposing of approved cardiovascular drugs. J Transl Med (2016) 0.75
[In Process Citation]. MMW Fortschr Med (2015) 0.75
Infant Colic. Semin Pediatr Neurol (2015) 0.75
Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience. Ital J Pediatr (2017) 0.75
Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterol (2016) 0.75
Infantile hemangioma status by dynamic infrared thermography: A preliminary study. Int J Dermatol (2016) 0.75
Temperature Instability in an Infant Treated with Propranolol for Infantile Hemangioma. J Pediatr Pharmacol Ther (2017) 0.75
Cardiovascular drugs in the treatment of infantile hemangioma. World J Cardiol (2016) 0.75
Drug repositioning in sarcomas and other rare tumors. EBioMedicine (2016) 0.75
Beta-adrenergic receptors are expressed across diverse cancers. Oncoscience (2017) 0.75
Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma. Front Oncol (2017) 0.75
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial. BMC Pediatr (2017) 0.75
[Acute complications of vascular anomalies in childhood]. Hautarzt (2017) 0.75
Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract. JCI Insight (2017) 0.75
A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol. Iran J Pharm Res (2017) 0.75
Clinician's Update on the Benign, Premalignant, and Malignant Skin Tumours of the Vulva: The Dermatologist's View. Int Sch Res Notices (2017) 0.75
Phytochemical Inhibition of Multidrug Resistance Protein-1 as a Therapeutic Strategy for Hemangioendothelioma. Antioxid Redox Signal (2016) 0.75
Adult neck hemangiolymphangioma: a case and review of its etiology, diagnosis and management. J Surg Case Rep (2017) 0.75
Intensive versus conventional glucose control in critically ill patients. N Engl J Med (2009) 26.30
Propranolol for severe hemangiomas of infancy. N Engl J Med (2008) 11.32
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis (2013) 5.40
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. Open AIDS J (2012) 4.20
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature (2011) 3.53
Monitoring cholesterol levels: measurement error or true change? Ann Intern Med (2008) 3.35
Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol (2010) 2.87
Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis. Horm Res (2006) 2.78
Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics (2009) 2.76
Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet (2003) 2.73
A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics (2011) 2.69
Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics (2009) 2.58
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation (2006) 2.58
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ Res (2013) 2.41
Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol (2013) 2.31
Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol (2007) 2.31
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer (2012) 2.29
Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation (2003) 2.28
Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics (2006) 2.28
Physiologic changes in vascular birthmarks during early infancy: Mechanisms and clinical implications. J Am Acad Dermatol (2009) 2.26
Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation (2009) 2.26
Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol (2008) 2.12
Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation (2006) 2.08
Sturge-Weber syndrome in patients with facial port-wine stain. Pediatr Dermatol (2011) 2.06
Response of tufted angiomas to low-dose aspirin. Pediatr Dermatol (2012) 2.04
The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J (2009) 2.03
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat (2008) 2.00
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol (2007) 2.00
Epidermolysis bullosa pruriginosa: a systematic review exploring genotype-phenotype correlation. Am J Clin Dermatol (2015) 1.99
Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology (2004) 1.98
Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr (2007) 1.96
A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol (2006) 1.95
Infantile transient smooth muscle contraction of the skin. J Am Acad Dermatol (2013) 1.95
Growth characteristics of infantile hemangiomas: implications for management. Pediatrics (2008) 1.95
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol (2002) 1.94
Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet (2004) 1.94
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics (2012) 1.91
Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. J Invest Dermatol (2012) 1.90
Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum (2012) 1.87
Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia. Eur Heart J (2011) 1.84
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) (2012) 1.84
Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol (2008) 1.83
Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol (2004) 1.81
Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol (2003) 1.81
Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest (2004) 1.80
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis (2009) 1.78
Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol (2005) 1.77
Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol (2005) 1.77
Inaccuracy of Wolff-Parkinson-white accessory pathway localization algorithms in children and patients with congenital heart defects. J Cardiovasc Electrophysiol (2006) 1.75
Vascular malformations: Part I. J Am Acad Dermatol (2007) 1.74
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol (2007) 1.74
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm (2010) 1.74
Pediatric anogenital warts: a 7-year review of children referred to a tertiary-care hospital in Montreal, Canada. Pediatr Dermatol (2006) 1.74
Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol (2006) 1.73
One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol (2003) 1.72
Inherited conduction system abnormalities--one group of diseases, many genes. J Cardiovasc Electrophysiol (2006) 1.69
Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. J Mol Cell Cardiol (2003) 1.67
Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome. J AAPOS (2009) 1.65
A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol (2006) 1.64
Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol (2002) 1.62
Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics (2010) 1.60
Mild traumatic brain injury among a cohort of rugby union players: predictors of time to injury. Br J Sports Med (2011) 1.60
Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol (2010) 1.59
The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development (2004) 1.59
Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm (2004) 1.59
Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol (2005) 1.58
Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest (2007) 1.57
"Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics (2013) 1.57
Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm (2006) 1.57
Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A (2002) 1.56
Infantile hemangiomas with unusually prolonged growth phase: a case series. Arch Dermatol (2008) 1.56
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev (2014) 1.56
Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm (2005) 1.55
The fetal cerebellum: development and common malformations. J Child Neurol (2011) 1.55
Neurocutaneous melanosis presenting with hydrocephalus. Case report and review of the literature. J Neurosurg (2005) 1.54